PDE1B and osteosarcoma: Further TIDE algorithms shed light on that patients with high-PDE1B expression would have a better immune response to immunotherapies than those with low-PDE1B expression, suggesting that elevated PDE1B gene expression could prevent immune escape from osteosarcoma.